Point Relief Coldspot Pain Relieving

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Point Relief Coldspot Pain Relieving
Generic name: MENTHOL
Manufacturer: Fabrication Enterprises Inc
Product type: HUMAN OTC DRUG
SPL set ID: 479fb728-4aeb-42e3-b238-f04255514baa
SPL ID: 583b17fe-f8b1-130f-e063-6294a90ab184
Version: 1
Effective date: 2026-08-05
Source export date: 2026-10-12
Source partition: 6
Source file: https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/b25dad4aaef9c88f0e827394a34fbbd1ce7d71422fa46b5d1e123befad498c1d/drug-label-0006-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 01:46:44

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Point Relief Coldspot Pain Relieving	openfda.brand_name
generic name		MENTHOL	openfda.generic_name
manufacturer name		Fabrication Enterprises Inc	openfda.manufacturer_name
ndc	package	51452-007-00	openfda.package_ndc
ndc	product	51452-007	openfda.product_ndc
ndc11	package	51452000700	derived:openfda.package_ndc
rxcui		2749120	openfda.rxcui
spl id		583b17fe-f8b1-130f-e063-6294a90ab184	id
spl set id		479fb728-4aeb-42e3-b238-f04255514baa	set_id
unii		L7T10EIP3A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings: • For external use only • Avoid contact with eyes • Do not apply to open wounds or damaged skin • If symptoms persist for more than seven days, discontinue use and consult physician Keep out of reach of children • If swallowed, consult physician • Do not bandage tightly

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.